WuXi Biologics (Cayman) Inc
2269.HK · Health Technology · Medical Specialties · CN
5,694 employees · wuxibiologics.com
About
WuXi Biologics (Cayman) Inc. is a company specializing in the development and manufacturing of biopharmaceuticals. It was founded in 2015 and is headquartered in Shanghai, China. WuXi Biologics is the world's largest biologics development and manufacturing services company and is also listed on the Hong Kong Stock Exchange.
Annual results
Reported figures, CNY · revenue up 16.7% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 21.8B | 4.9B | 22.5% | — |
| 2024 | 18.7B | 3.4B | 18.0% | — |
| 2023 | 17.0B | 3.4B | 20.0% | — |
| 2022 | 15.3B | 4.4B | 28.9% | — |
| 2021 | 10.3B | 3.4B | 32.9% | — |
2269.HK in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for WuXi Biologics (Cayman) Inc are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.